← Back to headlines
BTIG Raises Price Target on Rapport Therapeutics
BTIG has increased its price target for Rapport Therapeutics (RAPP), signaling a positive outlook for the company's stock.
5 Jun, 21:03 — 5 Jun, 21:03
Sources
Showing 1 of 1 sources
